V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290007342 | 290005658 | 1.77 | null | Palliative (P) | 2013-06-11 | 2013-07-04 | Cetuximab 14 day | 02 | N | 290020732 | EVEROLIMUS |
| 290007343 | 290005659 | 1.5 | 85.4 | Disease modification (D) | 2018-12-16 | 2018-12-16 | Carboplatin + Cetux + FU (>Cycle 2) | N | null | 290020868 | CAPE + CARBOPLATIN + CETUXIMAB |
| 290007344 | 290005660 | 1.87 | null | Palliative (P) | 2018-04-08 | 2018-04-15 | Paclitaxel (2 or 3 weekly) | N | Y | 290020908 | BEVACIZUMAB + CAPE + IRINOTECAN |
| 290007345 | 290005661 | 1.74 | 51.6 | Curative (C) | 2016-07-23 | 2016-07-23 | Panitumumab | N | Y | 290020936 | CARBOPLATIN + RT |
| 290007346 | 290005664 | 1.75 | 58.4 | Adjuvant (A) | 2017-12-01 | 2017-12-19 | DA | 02 | N | 290021044 | CAPECITABINE |
| 290007347 | 290005666 | null | 95.7 | Neo-adjuvant (N) | 2016-07-30 | 2016-09-15 | CARBOPLATIN + RT | N | N | 290021044 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290007348 | 290005667 | 1.58 | null | Palliative (P) | 2017-07-20 | 2017-07-25 | CAPECITABINE + MITOMYCIN + RT | N | null | 290021099 | CAPECITABINE + OXALIPLATIN |
| 290007349 | 290005668 | 1.77 | 79 | Curative (C) | 2013-01-20 | 2013-04-05 | LANREOTIDE | Y | Y | 290021428 | CARBOPLATIN |
| 290007350 | 290007410 | 1.74 | 108 | null | 2015-12-20 | 2015-12-27 | Sunitinib | 2 | N | 290021460 | CETUXIMAB + RT |
| 290007351 | 290005669 | 1.7 | 56.3 | Adjuvant (A) | 2016-08-21 | 2016-11-05 | Etoposide + Ifosfamide (5 days) | N | N | 290021582 | CARBOPLATIN + VINORELBINE |
| 290007352 | 290008072 | 1.61 | 93 | Palliative (P) | 2015-07-01 | 2015-07-28 | CAPECITABINE + OXALIPLATIN | 02 | N | 290021601 | LANREOTIDE |
| 290007353 | 290008072 | 0 | 0 | null | 2015-07-07 | 2015-07-14 | Capecitabine (14 day) + Irinotecan | 02 | N | 290021601 | LANREOTIDE |
| 290007354 | 290005670 | 1.87 | 80.05 | Adjuvant (A) | 2018-07-13 | 2018-07-26 | CAPECITABINE + MITOMYCIN + RT | null | N | 290021602 | CAPECITABINE |
| 290007355 | 290005670 | null | null | Curative (C) | 2015-08-11 | 2015-08-11 | CARBOPLATIN + ETOPOSIDE | 2 | N | 290021602 | TRASTUZUMAB |
| 290007356 | 290005673 | null | null | Palliative (P) | 2018-07-18 | 2019-01-07 | Capecitabine (21days) + Carboplatin | null | N | 290021884 | GEMCITABINE |
| 290007357 | 290005674 | 1.62 | null | Disease modification (D) | 2015-01-18 | 2015-01-18 | Trial Unspecified | null | N | 290021884 | LANREOTIDE |
| 290007358 | 290005675 | null | null | null | 2017-08-19 | 2017-08-19 | Docetaxel | N | null | 290021955 | CARBOPLATIN + ETOPOSIDE |
| 290007359 | 290005678 | 1.53 | 81.3 | null | 2016-09-07 | 2016-09-07 | Trifluridine + Tipiracil | 01 | N | 290022114 | CYCLOPHOSPHAMIDE |
| 290007360 | 290005678 | 1.57 | 38.8 | Palliative (P) | 2016-02-11 | 2016-02-11 | LANREOTIDE | 02 | N | 290022114 | CAPECITABINE + CISPLATIN |
| 290007361 | 290005678 | 1.7 | 41.9 | Adjuvant (A) | 2016-05-21 | 2017-01-13 | Capecitabine + Oxaliplatin 21day | N | N | 290022114 | CISPLATIN + RT |
| 290007362 | 290005679 | 1.67 | 63 | null | 2017-02-01 | 2017-02-01 | Capecitabine | Y | null | 290022316 | LANREOTIDE |
| 290007363 | 290005679 | 1.8 | 81.2 | Palliative (P) | 2018-03-07 | 2018-03-27 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 290022316 | CAPECITABINE |
| 290007364 | 290005680 | 1.63 | 86 | Curative (C) | 2015-06-21 | 2015-06-21 | Cisplatin + Radiotherapy | 2 | null | 290022572 | CISPLATIN + RT |
| 290007365 | 290005681 | 1.49 | 64.9 | null | 2014-08-24 | 2015-01-12 | Capecitabine + Oxaliplatin 21day | N | N | 290022572 | CETUXIMAB |
| 290007366 | 290007418 | 1.7 | 62.4 | Disease modification (D) | null | 2016-07-23 | MITOMYCIN | N | N | 290022837 | CISPLATIN + FLUOROURACIL + RT |
| 290007367 | 290005683 | 1.75 | 59.8 | Adjuvant (A) | null | 2015-10-06 | Cetuximab + FOLFIRI cycle1 | N | Y | 290022907 | CAPECITABINE + OXALIPLATIN |
| 290007368 | 290005684 | null | null | null | 2018-01-30 | 2018-01-30 | Cisplatin 100 + RT(H&N) 1 day | N | null | 290022921 | CAPECITABINE + OXALIPLATIN |
| 290007369 | 290005684 | null | 74 | Palliative (P) | 2017-03-25 | 2017-03-26 | Trial Unspecified | 02 | N | 290022921 | CARBOPLATIN + CETUXIMAB + FU |
| 290007370 | 290005684 | 1.52 | 38.9 | Curative (C) | 2018-07-03 | 2018-08-13 | CAPECITABINE + MITOMYCIN + RT | 99 | Y | 290022921 | CARBO + FLUOROURACIL |
| 290007371 | 290005685 | 1.56 | 69.2 | Palliative (P) | 2017-09-09 | 2017-10-15 | Capecitabine + Oxaliplatin 21day | 02 | N | 290023405 | CAPECITABINE |
| 290007372 | 290005687 | 1.85 | 77.7 | Curative (C) | 2016-03-20 | 2016-03-20 | CARBOPLATIN + ETOPOSIDE | N | N | 290023418 | CETUXIMAB |
| 290007373 | 290005690 | 1.54 | 67.55 | Adjuvant (A) | 2016-06-29 | 2016-06-29 | Capecitabine | N | N | 290023609 | CISPLATIN + RT |
| 290007374 | 290008077 | 1.52 | 66 | Adjuvant (A) | 2012-04-02 | 2013-10-16 | Capecitabine | 2 | N | 290023710 | PACLITAXEL + TRASTUZUMAB |
| 290007375 | 290008327 | 1.77 | 87.9 | Curative (C) | 2016-06-04 | 2016-06-04 | LANREOTIDE | N | N | 290023736 | CAPECITABINE + MITOMYCIN + RT |
| 290007376 | 290005691 | 1.68 | 73 | Disease modification (D) | 2019-05-13 | 2019-05-14 | CISPLATIN + RT | 2 | N | 290023882 | BORTEZOMIB + THALIDOMIDE |
| 290007377 | 290005692 | 1.62 | 75.4 | Palliative (P) | 2017-09-12 | 2018-02-24 | Cetuximab + Radiotherapy Maint | 2 | null | 290024091 | OCTREOTIDE |
| 290007378 | 290005693 | 1.63 | 48.5 | Curative (C) | null | 2017-01-02 | Capecitabine + Mitomycin | 2 | N | 290024141 | NOT MATCHED |
| 290007379 | 290005694 | null | null | Adjuvant (A) | 2018-10-08 | 2018-10-29 | Cisplatin 7 day | N | null | 290024165 | CAPECITABINE |
| 290007380 | 290005695 | 1.84 | 59.1 | Palliative (P) | null | 2016-07-09 | Docetaxel 75mg/m2 (21 day) | N | N | 290024230 | TRIAL |
| 290007381 | 290005696 | 1.46 | 86.8 | Palliative (P) | 2017-04-02 | 2017-09-13 | Ipilimumab | 02 | Y | 290024309 | CETUXIMAB |
| 290007382 | 290005697 | null | 48.1 | Palliative (P) | 2015-07-20 | 2015-11-03 | OCTREOTIDE | 02 | N | 290024495 | PANITUMUMAB |
| 290007383 | 290005698 | 1.78 | 81.2 | Adjuvant (A) | 2016-12-12 | 2016-12-12 | Capecitabine | 01 | N | 290024507 | CAPECITABINE + OXALIPLATIN |
| 290007384 | 290005698 | 1.8 | 88 | Palliative (P) | null | 2014-06-05 | Cisplatin | N | N | 290024507 | CETUXIMAB + IRINOTECAN + MDG |
| 290007385 | 290005699 | 1.73 | 97 | Adjuvant (A) | 2015-10-06 | 2015-10-27 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 290024760 | CAPECITABINE |
| 290007386 | 290005699 | 1.62 | 81.3 | Palliative (P) | 2015-09-14 | 2015-09-29 | Methotrexate intrathecal | 02 | N | 290024760 | TRASTUZUMAB + VINORELBINE |
| 290007387 | 290008079 | 1.58 | 74.4 | null | 2017-01-28 | 2017-03-11 | Trastuzumab 21 day maintenance | N | N | 290024972 | FLUOROURACIL + MITOMYCIN |
| 290007388 | 290005701 | 1.74 | 63 | Curative (C) | 2014-03-15 | 2014-03-15 | Capecitabine | N | N | 290025204 | CARBOPLATIN + CETUXIMAB + FU |
| 290007389 | 290007427 | null | null | Disease modification (D) | 2018-08-09 | 2018-08-09 | Fluorouracil PVI + Mitomycin 42 day | 02 | Y | 290025217 | BORTEZOMIB + THALIDOMIDE |
| 290007390 | 290005703 | 1.56 | 53.1 | Palliative (P) | 2018-02-21 | 2018-04-09 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 290025219 | CETUXIMAB |
| 290007391 | 290007428 | 1.59 | null | Neo-adjuvant (N) | 2015-04-13 | 2015-06-28 | CETUXIMAB | N | N | 290025303 | CAPECITABINE + OXALIPLATIN |